Previous studies have confirmed that the abnormal expression of SOX5 can promote the epithelial-stromal transformation (EMT), proliferation and invasion of cancers, including hepatocellular carcinoma, breast cancer, stomach cancer and prostate cancer, by targeting different downstream genes (such as Twist1, Snail and ZEBI) (55, 57). Here, SOX5 is linked to breast cancer.